GSK taps UK firm for 'beyond antibodies' drug technology Yahoo! News LONDON (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news) plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumours in ways antibody-based drugs cannot. |
